ESC Premium Access

Antithrombotic therapy in atrial fibrillation 1

Event: ESC CONGRESS 2016
Topic: Atrial fibrillation (AF)
Session type: Moderated Posters
Date: 29 August 2016
Time: 15:35 - 16:25

Congress Session

6 presentations in this session

Atrial fibrillation in haemodialysis patients without a vitamin K antagonist: Insight from the RAKUEN study

Speaker: Doctor W. Mitsuma (Niigata, JP)

Short-term risk of haemorrhage during heparin bridging at initiation of vitamin K antagonist therapy in patients with non-valvular atrial fibrillation managed in ambulatory care

Speaker: Doctor K. Bouillon (Saint Denis, FR)

Alcohol abuse is associated with increased risk of ischemic stroke in low risk patients with non-valvular atrial fibrillation.

Speaker: Doctor F. Al-Khalili (Stockholm, SE)

Do baseline characteristics account for geographical variations in event rates in patients with newly diagnosed atrial fibrillation? The GARFIELD-AF registry

Speaker: Professor K. Fox (Edinburgh, GB)

Death, stroke and major bleeding risk in patients older than 85 years with atrial fibrillation

Speaker: Doctor Y. Arnson (Kfar Saba, IL)

Increased use of oral anticoagulants in patients with atrial fibrillation: Nationwide temporal trends in Denmark from 2005 to 2015

Speaker: Mr K. Gadsboell (Hellerup, DK)

6 speakers from this session

Doctor Wataru Mitsuma

Shinrakuen hospital, Niigata (Japan)
0 follower

Doctor Kim Bouillon

French National Agency for Medicines and Health Products Safety (ANSM), Saint Denis (France)
0 follower

Doctor Faris Al-Khalili

Sophiahemmet, Stockholm (Sweden)
0 follower

Professor Keith Fox

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
36 presentations
0 follower

Doctor Yoav Arnson

Meir Medical Center, Kfar Saba (Israel)
0 follower

Mr Kasper Gadsboell

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)
0 follower

This platform is supported by

logo Novo Nordisk